Summary of Study ST001795
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001139. The data can be accessed directly via it's Project DOI: 10.21228/M8GH59 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST001795 |
| Study Title | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) |
| Study Type | Untargeted lipidomics analysis |
| Study Summary | Untargeted lipid profiling of mesenteric mice lymph from mice fed with CHOW, HFD and HFD supplemented with COx-2 inhibitor drug Celecoxib. It is proposed that Celecoxib can protect from deleterious morphological changes in lymphatic system caused by obesity/HFD. |
| Institute | Monash Institute of Pharmaceutical Sciences |
| Department | Drug Delivery, Disposition and Dynamics |
| Laboratory | Trevaskis Lab, Creek Lab |
| Last Name | Anderson |
| First Name | Dovile |
| Address | 6 Anderson |
| dovile.anderson@gmail.com | |
| Phone | 8671141 |
| Submit Date | 2021-05-12 |
| Num Groups | 3 |
| Total Subjects | 26 |
| Num Males | 26 |
| Publications | Manuscript NATMETAB-A20022406A Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential novel treatment target in obesity |
| Raw Data Available | Yes |
| Raw Data File Type(s) | raw(Thermo) |
| Analysis Type Detail | LC-MS |
| Release Date | 2021-06-02 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Treatment |
|---|---|---|
| SA167157 | Celecoxib_HFD_3 | Celecoxib_HFD |
| SA167158 | Celecoxib_HFD_9 | Celecoxib_HFD |
| SA167159 | Celecoxib_HFD_2 | Celecoxib_HFD |
| SA167160 | Celecoxib_HFD_5 | Celecoxib_HFD |
| SA167161 | Celecoxib_HFD_4 | Celecoxib_HFD |
| SA167162 | Celecoxib_HFD_8 | Celecoxib_HFD |
| SA167163 | Celecoxib_HFD_1 | Celecoxib_HFD |
| SA167164 | Celecoxib_HFD_7 | Celecoxib_HFD |
| SA167165 | Celecoxib_HFD_6 | Celecoxib_HFD |
| SA167149 | CFD_3 | CFD |
| SA167150 | CFD_2 | CFD |
| SA167151 | CFD_4 | CFD |
| SA167152 | CFD_7 | CFD |
| SA167153 | CFD_8 | CFD |
| SA167154 | CFD_1 | CFD |
| SA167155 | CFD_6 | CFD |
| SA167156 | CFD_5 | CFD |
| SA167166 | HFD_7 | HFD |
| SA167167 | HFD_8 | HFD |
| SA167168 | HFD_9 | HFD |
| SA167169 | HFD_6 | HFD |
| SA167170 | HFD_1 | HFD |
| SA167171 | HFD_2 | HFD |
| SA167172 | HFD_3 | HFD |
| SA167173 | HFD_4 | HFD |
| SA167174 | HFD_5 | HFD |
| Showing results 1 to 26 of 26 |
